Researchers in Singapore have re-engineered a harmless strain of bacteria to fight another common, drug-resistant microbe that spreads in hospitals and is deadly to patients with weak immune systems.
To fight the Pseudomonas aeruginosa bacterium, the scientists used a strain of the E.coli bacteria that is normally present in the human gut.
They inserted into E.coli foreign DNA fragments that empowered it to sense the offending pathogen and quickly produce and release a deadly toxin.
Experts redesign common microbe to fight drug-resistant bacteria - Tan Ee Lyn, Reuters
- PHYSICAL SCIENCES
- EARTH SCIENCES
- LIFE SCIENCES
- SOCIAL SCIENCES
Subscribe to the newsletter
Stay in touch with the scientific world!
Know Science And Want To Write?
- Part I: Bee Deaths Mystery Solved? Neonicotinoids (Neonics) May Actually Help Bee Health
- Smoking, Drinking And Eating: It's Not About Your Freedom
- Coffee Lowers Risk Of Alzheimer's Up To 20 Percent
- Part II: Bee Deaths And CCD - Flawed Chensheng Lu Harvard Studies Endanger Bees
- Diversity Fatigue: Why Businesses Struggle To Close The Gender Gap
- Like Collaboration And Intelligence In Humans? Thank War
- A Disturbance In The Force: 'Giant' Charge Density Oscillation Discovered In Nanomaterials
- "A note from THE SIN OF PROHIBITION by G.K.Chesterton:So if you wish to change corporate behaviour..."
- "How can diseases linked to smoking tobacco be on the rise when the smoking rate has been consistently..."
- "I was looking at The Winnower again this morning, which led me back here. I tried to comment on..."
- "There is no question they were created to cater to universities and are staffed by people from..."
- "And my second link should be not a copy of the first, but this: http://www.nature.com/news/half..."
- Behavioral interventions to prevent progression to diabetes equally effective in men and women
- Gender differences in adaptation to space flight
- Long-term complication rate low in nose job using patient's own rib cartilage
- Survival differences seen for advanced-stage laryngeal cancer
- Effect of once-daily, low-dose aspirin on heart attack deaths and other outcomes